Xinming Zhuo

Dr. Xinming Zhuo


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XZXinming Zhuo
Xinming Zhuo
QWQun Wang
Qun Wang
LVLiesbeth Vossaert
Liesbeth Vossaert
RSRoseen Salman
Roseen Salman
AKAdriel Kim
Adriel Kim
ABArthur Beaudet
Arthur Beaudet
A major challenge for cell-based non-invasive prenatal testing (NIPT) is to distinguish individual presumptive fetal cells from maternal cells in female pregnancies. We have sought a rapid, robust, versatile, and low-cost next-generation sequencing method to facilitate this process. Toward this goal, single isolated cells underwent whole genome amplification prior to genotyping. Multiple highly polymorphic genomic regions (including HLA-A and HLA-B) with 10–20 very informative single nucleotide polymorphisms (SNPs) within a 200 bp interval were amplified with a modified method based on other publications. To enhance the power of cell identification, approximately 40 Human Identification SNP (Applied Biosystems) test amplicons were also utilized. Using SNP results to compare to sex chromosome data from NGS as a reliable standard, the true positive rate for genotyping was 83.4%, true negative 6.6%, false positive 3.3%, and false negative 6.6%. These results would not be sufficient for clinical diagnosis, but they demonstrate the general validity of the approach and suggest that deeper genotyping of single cells could be completely reliable. A paternal DNA sample is not required using this method. The assay also successfully detected pathogenic variants causing Tay Sachs disease, cystic fibrosis, and hemoglobinopathies in single lymphoblastoid cells, and disease-causing variants in three cell-based NIPT cases. This method could be applicable for any monogenic diagnosis.


3 November 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MLMiles Liao
Miles Liao
XZXinming Zhuo
Xinming Zhuo
Background: Intragenic copy number variants (CNVs), including exon-level deletions and duplications within a single gene, represent an important class of pathogenic genomic variation. Their functional consequences depend on the precise relationship between the CNV breakpoints, exon structure, coding sequence boundaries, transcript orientation, and reading frame. Although intragenic CNVs contribute substantially to Mendelian disease, their interpretation remains difficult because many existing workflows rely on manual transcript review or annotation pipelines that do not consistently resolve exon-level and base-pair-level consequences. Results: We developed CNVision, a containerized computational framework for standardized interpretation of intragenic CNVs. CNVision accepts multiple input formats, including exon-based entries, genomic coordinates, and HGVS genomic notation, and converts each into a unified internal representation for transcript-aware analysis. The system maps CNVs to coding sequence regions, calculates affected coding sequence length at base-pair resolution, and classifies predicted reading-frame consequence. CNVision was evaluated using a dataset including 200 curated intragenic CNVs spanning multiple genes, genome builds, variant structures, and input types. Across the dataset, CNVision produced predictions concordant with manual transcript-level analysis and correctly processed exon-based, coordinate-based, and HGVS-formatted inputs. Beyond basic evaluation, CNVision also identified discrepancies in previously published CNVs. Of 131 reported CNVs evaluated, 15 yielded classifications that differed from the original published interpretation; independent manual transcript-level analysis using the UCSC Genome Browser supported CNVision’s classification in all 15 variants, indicating the discrepancies were attributable to differences in transcript interpretation or coordinate calculation rather than computational error. In terms of processing speed, CNVision was tested by two board-certified laboratory geneticists who compared the runtime of CNVision versus manual analysis across 18 CNVs, 6 of each input type. CNVision consistently outperformed manual analysis by both geneticists across all variants by a significant margin. Conclusion: CNVision provides a reproducible framework for functional interpretation of intragenic CNVs by automating input parsing, transcript mapping, coding sequence overlap calculation, and reading-frame classification. The framework reduces manual burden, improves consistency, and provides a foundation for future expansion into batch CNV processing and graphical variant interpretation.

2 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
XZXinming Zhuo
Xinming Zhuo
QWQun Wang
Qun Wang
VLVossaert Liesbeth
Vossaert Liesbeth
RSRoseen Salman
Roseen Salman
AKAdriel Kim
Adriel Kim
ABArthur Beaudet
Arthur Beaudet
A major challenge for cell-based non-invasive prenatal testing (NIPT) is to distinguish individual presumptive fetal cells from maternal cells in female pregnancies. We have sought a rapid, robust, versatile, and low-cost next-generation sequencing method to facilitate this process. Toward this goal, single isolated cells underwent whole genome amplification prior to genotyping. Multiple highly polymorphic genomic regions (including HLA-A and HLA-B) with 10-20 very informative single nucleotide polymorphisms (SNPs) within a 200 bp interval were amplified with a modified method based on other publications. To enhance the power of cell identification, approximately 40 Human Identification SNP (Applied Biosystems) test amplicons were also utilized. This method allowed reliable differentiation of fetal and maternal cells. In fully informative cases, two haplotypes were found within the maternal reads, and fetal cells showed reads with one but not the second maternal haplotype while also showing a novel paternal haplotype absent in the mother. For SNP typing, at least 2 SNPs and 10% of informative SNPs were required to differentiate a fetal cell from a maternal cell. A paternal DNA sample is not required using this method. The assay also successfully detected point mutations causing Tay Sachs disease, cystic fibrosis, and hemoglobinopathies in single lymphoblastoid cells, and monogenic disease-causing mutations in three cell-based NIPT cases. This method could be applicable for any monogenic diagnosis.